DCM Shriram Recommends 200% Final Dividend, Approves AGM on Aug 18, 2026
DCM Shriram recommended a final dividend of 200% (₹4 per share) for FY26, subject to shareholder approval at the AGM on August 18, 2026. The company also approved a ₹101 crore capex for its subsidiary HSCL to expand Formulated Resins capacity. Audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, were approved.
The declaration of a substantial final dividend and a significant capital expenditure plan for capacity expansion are material events that directly impact the company's financial performance and future growth prospects, thus having a high impact.
The company announced a significant final dividend recommendation and approved capital expenditure for capacity expansion, which are positive indicators for shareholders and business growth.
DCM Shriram Limited announced its audited financial results for the quarter and financial year ended March 31, 2026. The Board of Directors has recommended a final dividend of 200%, equivalent to ₹4 per equity share of face value ₹2 each, for the Financial Year ended March 31, 2026. This recommendation is subject to shareholder approval at the 37th Annual General Meeting (AGM), which is scheduled to be convened on Tuesday, August 18, 2026.
If approved, the total dividend for FY 2025-26 will aggregate to 560% (₹11.20 per equity share), comprising the first interim dividend of 180% (₹3.60) declared in October 2025 and the second interim dividend of 180% (₹3.60) declared in January 2026. The final dividend, if declared, will be paid within 30 days from the date of the AGM.
The Board also approved the convening of the 37th AGM on August 18, 2026. Additionally, the company is seeking shareholder approval for the cancellation of 39,00,000 forfeited equity shares. In a significant business update, the company's wholly-owned subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL), plans a capital investment of ₹101 crores to augment its Formulated Resins (FR) capacity by 36K TPA, bringing the total FR capacity to 50K TPA. DCM Shriram will provide financial assistance of up to ₹100 crores to HSCL for this expansion.
What to do with a filing like this
DCM Shriram Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCM Shriram Limited. Read the original for the full detail.